MALAYSIAN DENTAL JOURNAL
|
|
|
- Logan O’Connor’
- 9 years ago
- Views:
Transcription
1 Malaysian Dental Journal (2012) Volume 34 Issue 1 MALAYSIAN DENTAL JOURNAL A Retrospective Study of the Clinical Characteristics of Malaysian Trigeminal Neuralgia (TGN) Patients seen at the Oral Medicine Clinic, Kuala Lumpur General Hospital Sathasivam HP 1, Ahmad AR 2, Hin LS 3 1 Department of Dental, Hospital Sultan Ismail, Johor Bahru 2 Oral Medicine and Oral Pathology Specialist, Oral Surgery Clinic, Hospital Tengku Ampuan Afzan, Kuantan 3 Consultant Oral Medicine and Oral Pathology Specialist, Institute for Medical Research, Kuala Lumpur ABSTRACT Aim. This study was performed to address the lack of epidemiological as well as clinical data of trigeminal neuralgia (TGN) in Asian populations seen at dental specialist clinics with emphasis on the Malaysian population. Materials and Methods. Retrospective in nature involving evaluation and analysis of data obtained from the clinical records of 63 patients diagnosed with TGN between 1st January 2001 and 31st December 2010 and followed up at the Oral Medicine Clinic of the Kuala Lumpur General Hospital (KLGH) until 30th June Descriptive statistics was performed using the Statistical Package for Social Sciences software version 17. Results. Mean age at time of diagnosis with TGN was 58.2 (±12.0) years with peak incidences in the sixth and seventh decades of life. TGN presented predominantly in females (58.7 %). Mean follow-up period was 33.7 (±14.9) months. The ethnic distribution reflected their ratios in the general population of Malaysia. TGN more commonly affected the right side of the face. The most common pain descriptor used was sharp/stabbing pain. The mandibular branch was more commonly involved than the maxillary branch in this population of patients. Patients had diverse triggering stimuli/factors. All patients received only pharmacological treatment and most responded well to carbamazepine. Conclusion. The clinical characteristics of Asian TGN patients seen at the Oral Medicine Clinic are strikingly similar to Caucasian patients with the only obvious exception being the greater involvement of the mandibular branch of the trigeminal nerve amongst Asian patients compared to their Caucasian counterparts. Key Words: Not available Please cite this article as: Sathasivam HP, Ahmad AR, Hin LS. A Retrospective Study of the Clinical Characteristics of Malaysian Trigeminal Neuralgia (TGN) Patients seen at the Oral Medicine Clinic, Kuala Lumpur General Hospital. Malaysian Dental Journal 2012; 34(1): INTRODUCTION The International Headache Society (IHS) has defined trigeminal neuralgia (TGN) as a usually unilateral condition characterized by severe brief electric-shock like recurrent pain that is abrupt in both its onset and termination and limited to the sensory distribution of one or more branches of the fifth cranial nerve. 1 The exact aetiopathogenesis of TGN is still uncertain. Several hypotheses however, have been put forward, including compression of the trigeminal nerve by neoplastic or vascular anomalies; infectious agents; and demyelinating conditions such as multiple sclerosis (MS). The most popular theory is that of compression of the trigeminal nerve as it leaves the brainstem. It is believed that in % of patients, TGN is caused by compression of the trigeminal nerve root a few millimeters proximal to the pons by a loop of artery or vein. 2-6 Although a loop of blood vessel is usually to blame, there are other occasional causes of compression such as cysts, neoplasms, and structural deformities of the skull base. Although many articles have been published describing the demographic as well as the clinical characteristics of TGN, the majority were based on Caucasian populations. 4,7-12 As such, due to the relative paucity of demographic and clinical data concerning Asian TGN patients, a retrospective 8
2 study was performed. Peninsular Malaysia has a mixed Asian population with three main ethnic groups being the Malays, Chinese and Indians. It is hoped that information derived from this study would be useful to clinicians that are involved in the diagnosis and management of TGN. From this study, we also hope to be able to identify differences in the clinical characteristics of TGN between the different ethnic groups. Furthermore, it may provide us with a better understanding of possible predictive or prognostic factors associated with TGN. MATERIALS AND METHODS This study was retrospective in nature involving evaluation and analysis of data obtained from the clinical records of patients diagnosed with TGN between 1st January 2001 and 31st December 2010 and followed up at the Oral Medicine (OM) Clinic of Kuala Lumpur General Hospital (KLGH) until 30th June Ethics approval for this study was obtained from the Human Research Ethics Committee of the Institute for Medical Research, Malaysia. To minimize variability amongst the cases, the study was limited to patients who were diagnosed as having TGN by a dental specialist at KLGH. Patients with incomplete/inadequate treatment records, followed up for less than 6 months and who were lost to follow up, were all excluded. The clinical parameters studied included age (at time of diagnosis with TGN), gender, race, site of involvement, pain descriptor (used to describe the nature of pain), triggering activity, trigger zone, pre-existing systemic conditions such as diabetes mellitus, hypertension or multiple sclerosis, pharmacological agent used for management as well as response to management. Descriptive statistics was performed using the Statistical Package for Social Sciences software version 17 RESULTS In the span of 10 years, from 1st January 2001 until 31st December 2010, 72 patients were managed for TGN and of these only 63 patients satisfied the criteria for this study. Demographic factors Age of patients at time of diagnosis with TGN ranged from 27 to 81 years with a mean of 58.2 (±12.0) years. The peak incidence was in the sixth decade of life (33.3 %) followed by the seventh decade of life (27.0 %). Female patients predominated with 37 (58.7 %) cases altogether. This in turn gives a female to male ratio of 1.4:1. However, when the cases were stratified according to race, the gender bias was not present amongst the Chinese and Indian patients. With regards to the ethnic distribution, the majority of patients seen were Malays (55.6 %) followed by Chinese (27.0 %) and Indians (17.5 %). Table 1. Gender and racial distribution Gender RACE Male Female Total Malay Chinese Indian Total Medical comorbidities Of the 63 patients, 27 patients (42.9 %) had a positive history of hypertension and 9 patients (14.3 %) had a positive history of type 2 diabetes mellitus. None of the patients had a positive history for multiple sclerosis, brain tumours, mixed connective tissue disease, central or peripheral demyelinating diseases as well as any other disorders of the central or peripheral nervous system (excluding TGN). Clinical characteristics TGN predominantly affected the right side of the face, with 60.3 % of the patients presenting with pain on that side; giving a ratio of 1.5:1 favouring the right side of the face. The mandibular branch was more frequently involved than the maxillary branch of the trigeminal nerve, with 39 patients (61.9 %) having involvement of the mandibular branch of the trigeminal nerve. Of these 39 patients, 28 patients had pain confined solely to the distribution of the mandibular branch of the trigeminal nerve. The majority of patients (49.2 %) likened the pain experienced during an attack as a severe, sharp, stabbing sensation (lancinating). Other commonly used pain descriptors were throbbing pain (19.0 %), electric-current/electric shock like 9
3 feeling (17.5 %) and toothache-like (11.1 %). Two patients described experiencing a pulling type of sensation during these attacks. The most common triggering stimuli/activity was light/soft touch (52.4 %). Other triggering activities include eating, speaking, shaving, washing the face as well as smiling. Table 2. Distribution of TGN according to race and branch or trigeminal nerve Branch of Trigeminal Nerve Involved Maxillary Mandibular Opthalmic & Maxillary & Maxillary Mandibular Total RACE (V2) (V3) (V1 + V2) (V2 + V3) Malay Chinese Indian Total Treatment related Patients were managed pharmacologically with all patients achieving complete remission of symptoms to varying doses of carbamazepine. Dosage of carbamazepine used to manage the condition were tailored to each individual patient and ranged from 200 mg to 1200 mg per day in divided doses, with the mean dosage of carbamazepine being mg (± mg). Only the initial effective dose of carbamazepine where symptom remission was experienced by the patient was included in this study. The dosage of carbamazepine was gradually tapered down depending on the response. Five patients achieved complete remission and did not require sustained long-term pharmacological intervention. Two patients required addition of phenytoin, before symptomatic relief was achieved. The two patients who were non-responsive to single drug therapy were both of the female gender. As for the patients who achieved complete long-term remission, four were females. Due to the very small numbers and female predominance of TGN in this cohort, no comparisons could be made and no significant conclusions could be drawn from these trends. Patients were followed for a mean period of 33.7 (± 14.9) months. The most common adverse effect experienced by these patients was somnolence (93.7 %) followed by dizziness (58.7 %). No cases of severe adverse reactions such as thrombocytopenia or toxic epidermal necrolysis were seen amongst this cohort of patients. DISCUSSION Demographic factors The age related findings of this study are similar with many other studies that have reported TGN as a condition that is more frequently diagnosed between the 5th and 8th decades of life. 7,11-13 Even though TGN may be diagnosed in young adults, it is important that these patients undergo thorough neurological examination and assessment to exclude conditions like multiple sclerosis that may present with a similar clinical picture. This is the current practice at this center. The female predominance observed in this study is in line with other published work. 7,12,13 A previous study of TGN patients in India showed that males were more frequently afflicted with this condition compared to females. 14 One explanation as to why there is a female predominance overall, is the mere fact that on average, females have a longer lifespan than males. Although the gender bias was not seen amongst the Chinese and Indian patients, drawing a definitive conclusion is not plausible due to the relatively small number of these patients in this study. The racial distribution of the TGN patients is in concordance with the general racial distribution within the Kuala Lumpur area and as such, there is no obvious racial bias amongst Malaysian TGN patients. Clinical characteristics Predominant mandibular branch involvement is a feature that has been reported by other studies involving Asian patients as well. 13,15 The low 10
4 incidence of TGN involving the ophthalmic division has been reported by many other studies, and as such is not a very surprising finding However, before drawing conclusions regarding the possible predisposition of Asians towards involvement of the mandibular division in TGN, one must take into account that patients may consult other specialist units for management of TGN. It is highly likely that TGN patients with involvement of the ophthalmic and maxillary branches may have been managed by other specialists such as ophthalmologists or neurologists. As such, patients seen at this unit may not represent the total number of TGN patients seen at this hospital. Although there were no observed cases with bilateral involvement in our study, a previous study by Loh et al. 13 in Singaporean and Malaysian patients had a 6.8 % incidence of bilateral involvement. The study by Ariyawardana et al. 15 based on a Sri Lankan population on the other hand, did not observe any cases with bilateral involvement. It was suggested by Loh et al. 13 that the higher bilateral involvement could be unique to Asian patients, however, this generalization can only be made after analyzing a larger case series and taking into account the obvious differences amongst Asians of different races. Treatment related Management of TGN in most centers is performed through pharmacological means and surgical approaches are only employed in recalcitrant cases that fail to respond to medications. In our center, even though responsive to pharmacological treatment, some patients were given the option for surgical intervention. This option was given because the adverse effects experienced impaired their quality of life and ability to work. However, all of them were not keen on surgical intervention due to their apprehension towards surgery and preferred pharmacotherapy as they felt that they will be able to adjust to the adverse effects experienced. Carbamazepine has been for a long time the first line drug used for management of TGN. Not only is it highly effective, it is also sometimes used as a diagnostic adjunct for confirmation of the condition. CONCLUSION The clinical characteristics of Malaysian TGN patients are mostly similar to the patients from other parts of the world. The predominant involvement of the mandibular division of the trigeminal nerve amongst these patients is the most obvious difference observed when compared to Caucasian populations. This finding however needs to be verified by studying a larger series of patients and taking into the account the influence of race/ethnicity when analyzing the data. This study has shown that the racial profile of Malaysian TGN patients seen at the Oral Medicine Clinic is reflective of the overall racial profile of the Malaysian population with no obvious propensity for any one race towards development of this condition. Most patients were found to have responded well to pharmacological management of TGN using carbamazepine and experienced only mild adverse effects such as somnolence and dizziness. Due to the inherent problems associated with a small sample size, no prognostic indicators or predictive features for the development of TGN were found. Increasing the sample size as well as including the patients seen at other centers/units would perhaps yield more results. ACKNOWLEDGEMENT The authors would like to thank the Director of Health Malaysia for giving us permission to publish this paper. We would also like to thank the staff members of the Oral Medicine Clinic KLGH for all their kind assistance. REFERENCE 1. Classification Subcommittee of the International Headache Society: The international classification of headache disorders. Cephalalgia 2004, 24(1): Nurmikko TJ, Eldridge PR: Trigeminal neuralgia pathophysiology, diagnosis and current treatment. Br J Anaesth 2001, 87: Love S, Coakham HB: Trigeminal neuralgia: pathology and pathogenesis. Brain 2001, 124: Jensen TS, Rasmussen P, Reske-Nielsen E: Association of trigeminal neuralgia with 11
5 multiple sclerosis: clinical and pathological features. Acta Neurol Scand 1982, 65: Devor M, Govrin-Lippmann R, Rappaport ZH: Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 2002, 96: Miller JP, Acar F, Burchiel KJ: Classification of trigeminal neuralgia: clinical, therapeutic, and prognostic implications in a series of 144 patients undergoing microvascular decompression. J Neurosurg 2009, 111: Siqueira SR, Teixeira MJ, Siqueira JT: Clinical characteristics of patients with trigeminal neuralgia referred to neurosurgery. Eur J Dent 2009, 3: Tomasello F, Alafaci C, Angileri FF, Calisto A, Salpietro FM: Clinical presentation of trigeminal neuralgia and the rationale of microvascular decompression. Neurol Sci 2008, 29(Suppl 1):S Scrivani SJ, Mathews ES, Maciewicz RJ: Trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100: de Siqueira SR, Nobrega JC, Valle LB, Teixeira MJ, de Siqueira JT: Idiopathic trigeminal neuralgia: clinical aspects and dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98: Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT: Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, Neuroepidemiology 1991, 10: Katusic S, Beard CM, Bergstralh E, Kurland LT: Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, Ann Neurol 1990, 27: Loh HS, Ling SY, Shanmuhasuntharam P, Zain R, Yeo JF, Khoo SP: Trigeminal neuralgia. A retrospective survey of a sample of patients in Singapore and Malaysia. Aust Dent J 1998, 43: Kalyanaraman S, Ramamurthi B: Trigeminal neuralgia--a review of 331 cases. Neurol India 1970, 18(1): Ariyawardana A: KA, Vithanaarachchi N, Sitheeque M, Ranasinghe AW: Management of Trigeminal Neuralgia Retrospective Analysis of 61 Patients from Sri Lanka. Asian Journal of Oral Maxillofacial Surgery 2003, 15: Corresponding Author: Hans Prakash Sathasivam Oral Medicine & Oral Pathology Specialist Dental Department Hospital Sultan Ismail Johor Bahru, Malaysia [email protected] 12
Clinical Neurology and Neurosurgery
Clinical Neurology and Neurosurgery 114 (2012) 361 365 Contents lists available at SciVerse ScienceDirect Clinical Neurology and Neurosurgery journa l h omepage: www.elsevier.com/locate/clineuro Clinicopathological
Sinus Headache vs. Migraine
Sinus Headache vs. Migraine John M. DelGaudio, MD, FACS Professor and Vice Chair Chief of Rhinology and Sinus Surgery Department of Otolaryngology Emory University School of Medicine 1 Sinus Headache Problems
become a mainstay in the management of this painful condition.
J Neurosurg 96:527 531, 2002 Predictors of outcome in surgically managed patients with typical and atypical trigeminal neuralgia: comparison of results following microvascular decompression ELIZABETH C.
2.1 Who first described NMO?
History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first
Trigeminal Neuralgia. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health
Trigeminal Neuralgia U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health Trigeminal Neuralgia What is trigeminal neuralgia? Trigeminal neuralgia (TN), also
Neurovascular Orofacial Pain. Orofacial pain of potential neurovascular origin may mimic odontogenic pain to the extent that
Neurovascular Orofacial Pain Introduction Orofacial pain of potential neurovascular origin may mimic odontogenic pain to the extent that a large population of patients with migraine and trigeminal autonomic
Electronic Health Records Intake Form
Dr. Sam Yoder, D.C. 101 Winston Way Ste B Campbellsville, KY 42718 Electronic Health Records Intake Form In compliance with requirements for the government EHR incentive program First Name: Address: Last
X-Plain Trigeminal Neuralgia Reference Summary
X-Plain Trigeminal Neuralgia Reference Summary Introduction Trigeminal neuralgia is a condition that affects about 40,000 patients in the US every year. Its treatment mostly involves the usage of oral
TRIGEMINAL NEURALGIA PAIN SOCIETY OF THE PHILIPPINES PAI N S OCIETY OF I A S P PHILIPPINE CHAPTER
TRIGEMIAL EURALGIA PAI SOCIET OF THE PHILIPPIES PAI S OCIET OF THE 19 87 I A S P PHILIPPIE CHAPTER PHILIPP IE S Pain Society of the Philippines Suite 513 MAB St. Luke's Medical Center 279 E. Rodriguez
Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50
General Data Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization 2007 2012 N = 50 The vast majority of the patients in this study were diagnosed
HEADACHE. as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D.
HEADACHE as. MUDr. Rudolf Černý, CSc. doc. MUDr. Petr Marusič, Ph.D. Dpt. of Neurology Charles University in Prague, 2nd Faculty of Medicine Motol University Hospital History of headache 1200 years B.C.
Management of Trigeminal Neuralagia- An Update
Review Article Management of Trigeminal Neuralagia- An Update Vinayak.G Naik 1, Rakshit Vijay Sinai Khandeparker 1, Hunny Jain 2, Vikas Berwal 3, Savant Kiran 1 Department of Oral And Maxillofacial Surgery,
Mellen Center Approaches: Pain in Multiple Sclerosis
Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research 216.444.8600 Mellen Center Approaches: Pain in Multiple Sclerosis How often do MS patients have pain? The point prevalence of
Toothaches of Non-dental Origin
Toothaches of Non-dental Origin This brochure is produced by the American Academy of Orofacial Pain The American Academy of Orofacial Pain is an organization of health care professionals dedicated to alleviating
Clinically isolated syndrome (CIS)
Clinically isolated syndrome (CIS) Spirella Building, Letchworth, SG6 4ET 01462 476700 www.mstrust.org.uk reg charity no. 1088353 We hope you find the information in this factsheet helpful. If you would
Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas
Billing and Coding in Neurology and Headache Stuart B Black MD, FAAN Chief of Neurology Co-Medical Director: Neuroscience Center Baylor University Medical Center at Dallas CPT Codes vs. ICD Codes Category
Vision Health: Conditions, Disorders & Treatments NEUROOPTHALMOLOGY
Vision Health: Conditions, Disorders & Treatments NEUROOPTHALMOLOGY Neuroophthalmology focuses on conditions caused by brain or systemic abnormalities that result in visual disturbances, among other symptoms.
Long-Term Outcome of Trigeminal Nerve Injuries Related to Dental Treatment
DENTOALVEOLAR SURGERY J Oral Maxillofac Surg 69:2284-2288, 2011 Long-Term Outcome of Trigeminal Nerve Injuries Related to Dental Treatment M. Anthony Pogrel, DDS, MD, FACS, FRCS,* Ryan Jergensen, DDS,
Natural Modality in the Treatment of Primary Headaches. William S. Mihin, D.C. Catharine Helms, M.S. Michelle M. Anderson, M.S.N., F.N.P.
Natural Modality in the Treatment of Primary Headaches William S. Mihin, D.C. Catharine Helms, M.S. Michelle M. Anderson, M.S.N., F.N.P. Abstract Headaches are both a prevalent and disabling condition.
HEADACHES AND THE THIRD OCCIPITAL NERVE
HEADACHES AND THE THIRD OCCIPITAL NERVE Edward Babigumira M.D. FAAPMR. Interventional Pain Management, Lincoln. B. Pain Clinic, Ltd. Diplomate ABPMR. Board Certified Pain Medicine No disclosures Disclosure
UBC Pain Medicine Residency Program: CanMEDS Goals and Objectives of the Neurology Rotation
UBC Pain Medicine Residency Program: CanMEDS Goals and Objectives of the Neurology Rotation Goals of the Program To acquire the knowledge and skills necessary to assess and provide a management plan for
New daily persistent headache in the paediatric population
doi:10.1111/j.1468-2982.2008.01647.x New daily persistent headache in the paediatric population E Kung 1, SJ Tepper 2, AM Rapoport 3, FD Sheftell 4 & ME Bigal 1,5 1 Department of Neurology, Albert Einstein
Guideline for the Management of Acute Peripheral Facial nerve palsy. Bells Palsy in Children
Guideline for the Management of Acute Peripheral Facial nerve palsy Definition Bells Palsy in Children Bell palsy is an acute, idiopathic unilateral lower motor neurone facial nerve palsy that is not associated
1: Motor neurone disease (MND)
1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor
The clinical efficacy and safety of stereotactic radiosurgery (gamma knife) in the treatment of trigeminal neuralgia
J.N.W. Lim 1* L. Ayiku 2 The clinical efficacy and safety of stereotactic radiosurgery (gamma knife) in the treatment of trigeminal neuralgia 1 Nuffield Institute for Health, University of Leeds 2 School
Spinal Cord Stimulation (SCS) Therapy: Fact Sheet
Spinal Cord Stimulation (SCS) Therapy: Fact Sheet What is SCS Therapy? Spinal cord stimulation (SCS) may be a life-changing 1 surgical option for patients to control their chronic neuropathic pain and
CHPN Review Course Pain Management Part 1 Hospice and Palliative Nurses Association
CHPN Review Course Pain Management Part 1 Disclosures Bonnie Morgan has no real or perceived conflicts of interest that relate to this presentation. Copyright 2015 by the. HPNA has the exclusive rights
ECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
DIAGNOSTIC CRITERIA OF STROKE
DIAGNOSTIC CRITERIA OF STROKE Diagnostic criteria are used to validate clinical diagnoses. Here below MONICA diagnostic criteria are reported. MONICA - MONItoring trends and determinants of CArdiovascular
BOTOX Treatment. for Chronic Migraine. Information for patients and their families. Botulinum Toxin Type A
BOTOX Treatment Botulinum Toxin Type A for Chronic Migraine Information for patients and their families. Is Chronic Migraine the same as Migraine? Chronic Migraine is similar to migraine as sufferers experience
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
2.0 Synopsis. Vicodin CR (ABT-712) M05-765 Clinical Study Report R&D/07/095. (For National Authority Use Only) to Part of Dossier: Volume:
2.0 Synopsis Abbott Laboratories Name of Study Drug: Vicodin CR Name of Active Ingredient: Hydrocodone/Acetaminophen Extended Release (ABT-712) Individual Study Table Referring to Part of Dossier: Volume:
Atherosclerosis of the aorta. Artur Evangelista
Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis
Chronic Low Back Pain
Chronic Low Back Pain North American Spine Society Public Education Series What is Chronic Pain? Low back pain is considered to be chronic if it has been present for longer than three months. Chronic low
嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
Running Head: INTERNET USE IN A COLLEGE SAMPLE. TITLE: Internet Use and Associated Risks in a College Sample
Running Head: INTERNET USE IN A COLLEGE SAMPLE TITLE: Internet Use and Associated Risks in a College Sample AUTHORS: Katherine Derbyshire, B.S. Jon Grant, J.D., M.D., M.P.H. Katherine Lust, Ph.D., M.P.H.
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013. National Registry of Diseases Office (NRDO)
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013 National Registry of Diseases Office (NRDO) Released November 3, 2014 Acknowledgement This report was
The new ASISA standardised critical illness definitions what difference will they actually make to you? Paul Lewis Deputy Managing Director - Gen Re
The new ASISA standardised critical illness definitions what difference will they actually make to you? Paul Lewis Deputy Managing Director - Gen Re Contents Background What is SCIDEP Positioning The actual
Headaches and Kids. Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital
Headaches and Kids Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital Overview Headache classifications and diagnosis Address common headache
Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON
Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON First-line DMTs Reduce Relapse Frequency by ~30% vs. Placebo Frequency of relapse with various DMTs, based
Guide to Claims against General Practitioners (GPs)
Patients often build up a relationship of trust with their GP over a number of years. It can be devastating when a GP fails in his or her duty to a patient. Our medical negligence solicitors understand
Coronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
Minimally Invasive Spine Surgery For Your Patients
Minimally Invasive Spine Surgery For Your Patients Lukas P. Zebala, M.D. Assistant Professor Orthopaedic and Neurological Spine Surgery Department of Orthopaedic Surgery Washington University School of
Eastern Health MS Service. Tysabri Therapy. Information for People with MS and their Families
Eastern Health MS Service Tysabri Therapy Information for People with MS and their Families The Eastern Health MS Service has developed this information for you as a guide through what will happen to you
Parkinson s prevalence in the United Kingdom (2009)
Parkinson s prevalence in the United Kingdom (2009) Contents Summary 3 Background 5 Methods 6 Study population 6 Data analysis 7 Results 7 Parkinson's prevalence 7 Parkinson's prevalence among males and
Tension-type headache Non-pharmacological and pharmacological treatment
Danish Headache Center Tension-type headache Non-pharmacological and pharmacological treatment Lars Bendtsen Associate professor, MD, PhD, Dr Med Sci Danish Headache Center, Department of Neurology Glostrup
INITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
Trauma Insurance Claims Seminar Invitation
Trauma Insurance Claims Seminar Invitation Introduction Since the development of Trauma Insurance in Australia in the 1980s, the product has evolved at a great pace. Some of the challenges faced by claims
Introduction Hemophilia is a rare bleeding disorder in which the blood does not clot normally. About 1 in 10,000 people are born with hemophilia.
Hemophilia Introduction Hemophilia is a rare bleeding disorder in which the blood does not clot normally. About 1 in 10,000 people are born with hemophilia. Hemophilia can be mild, moderate, or severe.
John E. O Toole, Marjorie C. Wang, and Michael G. Kaiser
Hypothermia and Human Spinal Cord Injury: Updated Position Statement and Evidence Based Recommendations from the AANS/CNS Joint Sections on Disorders of the Spine & Peripheral Nerves and Neurotrauma &
Pricing the Critical Illness Risk: The Continuous Challenge.
Pricing the Critical Illness Risk: The Continuous Challenge. To be presented at the 6 th Global Conference of Actuaries, New Delhi 18 19 February 2004 Andres Webersinke, ACTUARY (DAV), FASSA, FASI 9 RAFFLES
A SAFE, NON-INVASIVE TREATMENT OPTION: GAMMA KNIFE PERFEXION
A SAFE, NON-INVASIVE TREATMENT OPTION: GAMMA KNIFE PERFEXION Not actually a knife, the Gamma Knife Perfexion is an advanced radiosurgery device which uses extremely precise beams of radiation to treat
Carpal Tunnel Syndrome
Carpal Tunnel Syndrome Information for patients Therapy Services Phone no: 01625 661481 www.eastcheshire.nhs.uk @eastcheshirenhs Ref: 11437 Review: 06/2015 Carpal Tunnel Syndrome Ref: 11437 Page 1 Review:
NICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
Multiple Sclerosis Society of Canada. CADA Presentation May 4, 2011
Multiple Sclerosis Society of Canada CADA Presentation May 4, 2011 1 MS Society s Mission To be a leader in finding a cure for multiple sclerosis and enabling people affected by MS to enhance their quality
What Is an Arteriovenous Malformation (AVM)?
What Is an Arteriovenous Malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair 1 What
OHTAC Recommendation
OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the
Headaches + Facial pain
Headaches + Facial pain Introduction: Each of us experienced sporadically/ chronically headache 40% worldwide population suffers with severe, disabling headache at least annually Common ailment Presenting
Multiple Sclerosis & MS Ireland Media Fact Sheet
Multiple Sclerosis & MS Ireland Media Fact Sheet This fact sheets gives a summary of the main facts and issues relating to Multiple Sclerosis and gives an overview of the services offered by MS Ireland.
why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3
Elite coverage can help protect your savings. USAble Life s 1 coverage helps protect your family from the financial impact that can occur as the result of a heart attack, stroke or even cancer by providing
Learn More About Product Labeling
Learn More About Product Labeling Product label The product label is developed during the formal process of review and approval by regulatory agencies of any medicine or medical product. There are specific
Concentrated Oral Aloe Vera for Alleviating IC Symptoms A White Paper
Concentrated Oral Aloe Vera for Alleviating IC Symptoms A White Paper A survey was sent to approximately 20,000 individuals who have taken Aloe Vera, primarily for interstitial cystitis (IC). A total of
AMSC College, Vocational Nursing Program, Course Outline Page 1/29 VOCATIONAL NURSING PROGRAM COURSE OUTLINE
AMSC College, Vocational Nursing Program, Course Outline Page 1/29 AMERICAN MEDICAL SCIENCES CENTER VOCATIONAL NURSING PROGRAM COURSE OUTLINE Date of Revision 02 22, 2013 AMSC College, Vocational Nursing
Written Example for Research Question: How is caffeine consumption associated with memory?
Guide to Writing Your Primary Research Paper Your Research Report should be divided into sections with these headings: Abstract, Introduction, Methods, Results, Discussion, and References. Introduction:
Sample Treatment Protocol
Sample Treatment Protocol 1 Adults with acute episode of LBP Definition: Acute episode Back pain lasting
ß-interferon and. ABN Guidelines for 2007 Treatment of Multiple Sclerosis with. Glatiramer Acetate
ABN Guidelines for 2007 Treatment of Multiple Sclerosis with ß-interferon and Glatiramer Acetate Published by the Association of British Neurologists Ormond House, 27 Boswell Street, London WC1N 3JZ Contents
Understanding. Peripheral Neuropathy. Lois, diagnosed in 1998, with her husband, Myron.
Understanding Peripheral Neuropathy Lois, diagnosed in 1998, with her husband, Myron. What Is Peripheral Neuropathy? Peripheral neuropathy is a nerve disorder. It may cause numbness, tingling, and weakness.
Michigan Department of Community Health
Michigan Department of Community Health January 2007 INTRODUCTION The Michigan Department of Community Health (MDCH) asked Public Sector Consultants Inc. (PSC) to conduct a survey of licensed dental hygienists
Treating Bulging Discs & Sciatica. Alexander Ching, MD
Treating Bulging Discs & Sciatica Alexander Ching, MD Disclosures Depuy Spine Teaching and courses K2 Spine Complex Spine Study Group Disclosures Take 2 I am a spine surgeon I like spine surgery I believe
Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases
Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several
How To Use A Drug In Multiple Sclerosis
Revised (2009) guidelines for prescribing in multiple sclerosis INTRODUCTION In January 2001, the (ABN) first published guidelines for the use of licensed disease modifying treatments (ß-interferon and
Prevalence of Parkinsonism and its aetiological subtypes within patients with movement disorders
Research papers Prevalence of and its aetiological subtypes within patients with movement disorders D G S V D Gajasinghe* AL 2002 batch of students, Faculty of Medicine, University of Colombo Abstract
Frequent headache is defined as headaches 15 days/month and daily. Course of Frequent/Daily Headache in the General Population and in Medical Practice
DISEASE STATE REVIEW Course of Frequent/Daily Headache in the General Population and in Medical Practice Egilius L.H. Spierings, MD, PhD, Willem K.P. Mutsaerts, MSc Department of Neurology, Brigham and
STEREOTACTIC RADIOSURGERY COMMISSIONING POLICY
STEREOTACTIC RADIOSURGERY COMMISSIONING POLICY Release Version 3.1 Date: 21 st September 2006 Author: Owner: Client: Ian Langfield, Service Group Commissioner, HCW Ian Langfield, Service Group Commissioner,
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within
Significant nerve damage is uncommonly associated with a general anaesthetic
Risks associated with your anaesthetic Section 10: Nerve damage associated with an operation under general anaesthetic Section 10: Significant nerve damage is uncommonly associated with a general anaesthetic
What You Should Know About Cerebral Aneurysms
What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,
Guide to Eye Surgery and Eye-related Claims
If you or a loved one have suffered because of a negligent error during eye treatment or surgery, you may be worried about how you will manage in the future, particularly if your eyesight has been made
Medical wisdom says that migraines reduce as people age - they are most common in the productive years and therefore migraine attacks should not be a
Migraine at 65 Medical wisdom says that migraines reduce as people age - they are most common in the productive years and therefore migraine attacks should not be a major problem in later life. Studies
THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS
THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS Introduction The following document has been produced by the Department of Health in partnership with the Association of British Insurers,
6/3/2011. High Prevalence and Incidence. Low back pain is 5 th most common reason for all physician office visits in the U.S.
High Prevalence and Incidence Prevalence 85% of Americans will experience low back pain at some time in their life. Incidence 5% annual Timothy C. Shen, M.D. Physical Medicine and Rehabilitation Sub-specialty
CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal
CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal 1. STUDY TITLE: Longitudinal Assessment of Chronic Health Conditions: The Aging of Childhood Cancer Survivors 2. WORKING GROUP AND INVESTIGATORS:
A Retrospective Review of Treatment of the Odontogenic Keratocyst
A Retrospective Review of Treatment of the Odontogenic Keratocyst J Oral Maxillofac Surg 63:635-639, 2005 Teresa A. Morgan, DDS, MS,* Christopher C. Burton, DDS, MS, and Fang Qian, MA, PhD Purpose: The
Gamma Knife Surgery for Trigeminal Neuralgia: Outcomes and Prognostic Factors. Jason Sheehan, MD, PhD, Hung-Chuan Pan, MD,
1 Gamma Knife Surgery for Trigeminal Neuralgia: Outcomes and Prognostic Factors Jason Sheehan, MD, PhD, Hung-Chuan Pan, MD, Matei Stroila, PhD, Ladislau Steiner, MD, PhD Lars Leksell Center for Gamma Surgery
Interventional MRI (imri) guided Deep Brain Stimulation for Parkinson s Disease
Interventional MRI (imri) guided Deep Brain Stimulation for Parkinson s Disease Anesthetic considerations A case study Lydia Cendana University of Pittsburgh School of Nurse Anesthesia Parkinson s disease
Committee Approval Date: December 12, 2014 Next Review Date: December 2015
Medication Policy Manual Policy No: dru299 Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective Date: January
Crohn's disease and pregnancy.
Gut, 1984, 25, 52-56 Crohn's disease and pregnancy. R KHOSLA, C P WILLOUGHBY, AND D P JEWELL From the Gastroenterology Unit, Radcliffe Infirmary, Oxford SUMMARY Infertility and the outcome of pregnancy
DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
Roche s marketing applications for review of OCREVUS (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA
Media Release Basel, 28 June 2016 Roche s marketing applications for review of OCREVUS (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA OCREVUS is the first investigational medicine
Graduate Program Objective #1 Course Objectives
1 Graduate Program Objective #1: Integrate nursing science and theory, biophysical, psychosocial, ethical, analytical, and organizational science as the foundation for the highest level of nursing practice.
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
London, 22 October 2009 Doc. Ref. EMEA/CHMP/EWP/692702/2008 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) REFLECTION PAPER ON THE EXTRAPOLATION OF RESULTS FROM CLINICAL STUDIES CONDUCTED OUTSIDE
Reversibility of Acute Demyelinating Lesions in relapsingremitting
Reversibility of Acute Demyelinating Lesions in relapsingremitting Multiple Sclerosis Omar A. Khan ( Division of Neuroimmunology, Department of Neurology, Neurology and Research Services. Veterans Affairs
